$1.7 Trillion Clean Energy Mandate to Deliver Stock Gains in 2021

From Resource Stock Digest | Ad

Newly-minted stock market millionaires will be making a tour de force in 2021 by being early on select green energy stocks. This US$0.25 stock just seized control of an ultra-rare clean energy metal America needs to lead the green energy revolution.

Smart investors will not be hesitating on this one.

BHVN Insider Trading (Biohaven Pharmaceutical)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 15.20%

Insider Buying (Last 12 Months): $2,889,912.50

Insider Selling (Last 12 Months): $45,180,324.95

Biohaven Pharmaceutical Insider Trading History Chart

Biohaven Pharmaceutical Share Price & Price History

^$100.40

▼ -4.62 (-4.40%)

As of 06/14/2021 01:00 AM ET

Days: 30 | 90 | 365

Here’s the Safest Way to Get Insanely Rich in the 2021 Gold Bull Market

From Resource Stock Digest | Ad

Gold is screaming higher and smart investors are already cashing in on the #1 Gold Pick of 2021. Yet, you haven’t missed the boat. See how this newly-listed US$5 gold stock offers investors historic gains without mining a single ounce of the metal.

Get the details here...

Biohaven Pharmaceutical Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/17/2021	John W Childs	Director	Buy	13,157	$76.00	$999,932.00
3/2/2021	John W Childs	Director	Buy	10,000	$85.14	$851,400.00	2,532,644
11/23/2020	John W Childs	Director	Buy	5,000	$89.55	$447,750.00	2,516,938
11/2/2020	William A Jones Jr	Insider	Sell	30,000	$76.22	$2,286,600.00	31,755
10/22/2020	Gregory Bailey	Director	Sell	24,566	$79.47	$1,952,260.02	2,559,161
10/19/2020	Gregory Bailey	Director	Sell	4,554	$78.98	$359,674.92	2,585,181
10/16/2020	Gregory Bailey	Director	Sell	3,748	$78.88	$295,642.24	2,585,181
10/12/2020	Gregory Bailey	Director	Sell	6,729	$78.87	$530,716.23	2,588,929
10/8/2020	Kimberly Gentile	SVP	Sell	23,500	$76.34	$1,793,990.00	27,139
9/21/2020	John W Childs	Director	Buy	3,322	$59.25	$196,828.50	2,511,938
9/11/2020	John W Childs	Director	Buy	6,678	$59.00	$394,002.00	2,508,616
7/8/2020	Gregory Bailey	Director	Sell	50,000	$75.22	$3,761,000.00	2,601,649
7/8/2020	Robert Berman	Insider	Sell	58,404	$75.25	$4,394,901.00	58,745
6/24/2020	Gregory Bailey	Director	Sell	3,995	$69.86	$279,090.70	2,737,829
6/23/2020	Robert Berman	Insider	Sell	4,296	$75.05	$322,414.80	4,637
6/22/2020	Gregory Bailey	Director	Sell	80,331	$73.24	$5,883,442.44	2,973,646
6/19/2020	Gregory Bailey	Director	Sell	164,031	$71.22	$11,682,287.82	2,973,646
6/18/2020	Robert Berman	Insider	Sell	61,314	$75.27	$4,615,104.78	36,655
6/17/2020	Kimberly Gentile	SVP	Sell	24,000	$70.20	$1,684,800.00	27,639
6/15/2020	Declan Doogan	Director	Sell	80,000	$66.73	$5,338,400.00	373,913
6/12/2020	Declan Doogan	Director	Sell	160,000	$66.00	$10,560,000.00	373,913
6/12/2020	Elyse Stock	Insider	Sell	36,966	$66.00	$2,439,756.00	22,560
6/11/2020	James Engelhart	CFO	Sell	73,725	$66.00	$4,865,850.00	15,975
6/10/2020	John Tilton	Insider	Sell	52,000	$67.38	$3,503,760.00	52,770
6/8/2020	Kimberly Gentile	SVP	Sell	600	$70.05	$42,030.00	4,239
4/6/2020	John W Childs	Director	Sell	150,000	$31.25	$4,687,500.00	2,682,279
1/22/2020	Eric Aguiar	Director	Sell	2,021	$56.48	$114,146.08
1/9/2020	Eric Aguiar	Director	Sell	30,000	$56.39	$1,691,700.00	30,000
12/30/2019	Robert Berman	Insider	Sell	125,000	$53.22	$6,652,500.00	125,341
12/16/2019	Eric Aguiar	Director	Sell	3,537	$55.13	$194,994.81
12/9/2019	Eric Aguiar	Director	Sell	4,072	$55.11	$224,407.92
11/22/2019	Eric Aguiar	Director	Sell	1,250	$55.24	$69,050.00	12,000
11/20/2019	Eric Aguiar	Director	Sell	6,729	$52.20	$351,253.80
11/20/2019	Kimberly Gentile	SVP	Sell	3,935	$53.03	$208,673.05	3,935
10/18/2019	Elyse Stock	Insider	Sell	17,700	$45.07	$797,739.00	17,700
10/15/2019	Elyse Stock	Insider	Sell	800	$45.01	$36,008.00	800
9/11/2019	Eric Aguiar	Director	Sell	10,000	$45.00	$450,000.00
8/20/2019	Gregory Bailey	Director	Buy	5,000	$37.65	$188,250.00	2,587,601
6/27/2019	James Engelhart	CFO	Buy	2,500	$43.05	$107,625.00
6/26/2019	John W. Childs	Director	Buy	10,000	$40.37	$403,700.00
6/26/2019	Vlad Coric	CEO	Buy	5,000	$40.22	$201,100.00
4/16/2019	Declan Doogan	Director	Sell	88,825	$58.42	$5,189,156.50	373,913
4/12/2019	Declan Doogan	Director	Sell	38,825	$53.92	$2,093,444.00	373,913
3/26/2019	Declan Doogan	Director	Sell	11,175	$53.69	$599,985.75	373,913
3/22/2019	Declan Doogan	Director	Sell	5,351	$53.66	$287,134.66	373,913
3/14/2019	Vlad Coric	CEO	Sell	100,000	$50.09	$5,009,000.00
3/12/2019	John Tilton	Insider	Sell	10,000	$50.11	$501,100.00	10,000
3/12/2019	Vlad Coric	CEO	Sell	51,962	$50.15	$2,605,894.30
3/1/2019	Declan Doogan	Director	Sell	50,595	$47.17	$2,386,566.15	394,083
2/27/2019	Declan Doogan	Director	Sell	27,045	$45.02	$1,217,565.90	394,083
2/21/2019	Julia P Gregory	Director	Sell	12,000	$43.56	$522,720.00	12,000
2/19/2019	Declan Doogan	Director	Sell	2,078	$45.48	$94,507.44
2/13/2019	Declan Doogan	Director	Sell	40,000	$44.31	$1,772,400.00
1/10/2019	John Tilton	Insider	Sell	10,500	$37.67	$395,535.00	10,500
6/15/2018	Kimberly Gentile	VP	Sell	12,500	$40.02	$500,250.00	12,500

SEC Filings (Institutional Ownership Changes) for Biohaven Pharmaceutical (NYSE:BHVN)

92.11% of Biohaven Pharmaceutical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Biohaven Pharmaceutical Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
6/14/2021	Knoll Capital Management LLC	856,844	$58.57M	38.2%	-0.1%	1.317%
5/28/2021	Schroder Investment Management Group	53,928	$3.69M	0.0%	+20.8%	0.083%
5/24/2021	Principal Financial Group Inc.	187,870	$12.84M	0.0%	+540.2%	0.289%
5/22/2021	Teachers Retirement System of The State of Kentucky	10,320	$0.71M	0.0%	-5.4%	0.016%
5/19/2021	Bamco Inc. NY	146,000	$9.98M	0.0%	-8.0%	0.224%
5/18/2021	Millennium Management LLC	53,616	$3.67M	0.0%	-41.8%	0.082%
5/18/2021	Voloridge Investment Management LLC	24,930	$1.70M	0.0%	-3.1%	0.038%
5/18/2021	Opaleye Management Inc.	25,000	$1.71M	0.3%	-78.1%	0.038%
5/18/2021	D. E. Shaw & Co. Inc.	138,335	$9.46M	0.0%	-31.3%	0.213%
5/18/2021	State of Wisconsin Investment Board	64,800	$4.43M	0.0%	-39.7%	0.100%
5/18/2021	Morgan Stanley	41,109	$2.81M	0.0%	-71.0%	0.063%
5/18/2021	Tudor Investment Corp Et Al	92,658	$6.33M	0.1%	+2,139.7%	0.142%
5/18/2021	Cormorant Asset Management LP	200,000	$13.67M	0.3%	-52.9%	0.307%
5/18/2021	Cubist Systematic Strategies LLC	3,114	$0.21M	0.0%	-93.7%	0.005%
5/18/2021	Twinbeech Capital LP	12,350	$0.84M	0.1%	+13.6%	0.019%
5/18/2021	Glenview Capital Management LLC	458,600	$31.35M	0.5%	N/A	0.705%
5/18/2021	California State Teachers Retirement System	77,648	$5.31M	0.0%	-0.3%	0.119%
5/18/2021	Silverarc Capital Management LLC	50,089	$3.42M	1.9%	+203.6%	0.077%
5/17/2021	AQR Capital Management LLC	20,027	$1.37M	0.0%	-0.9%	0.031%
5/17/2021	Virtus ETF Advisers LLC	7,193	$0.49M	0.2%	+2.8%	0.011%
5/17/2021	Royal Bank of Canada	35,240	$2.41M	0.0%	-10.8%	0.054%
5/17/2021	Armistice Capital LLC	1,000,000	$68.35M	1.6%	+74.8%	1.537%
5/17/2021	Polar Capital Holdings Plc	861,827	$58.91M	0.4%	+7.4%	1.324%
5/17/2021	Price T Rowe Associates Inc. MD	154,547	$10.56M	0.0%	-0.1%	0.237%
5/17/2021	DAFNA Capital Management LLC	93,600	$6.40M	1.5%	+14.0%	0.144%
5/17/2021	Davide Leone & Partners Investment Co Ltd.	29,395	$2.01M	0.3%	+54.6%	0.045%
5/17/2021	Woodline Partners LP	188,256	$12.87M	0.3%	N/A	0.289%
5/17/2021	Caption Management LLC	12,600	$0.86M	0.0%	-50.6%	0.019%
5/17/2021	Caas Capital Management LP	86,985	$5.95M	0.1%	-274.0%	0.134%
5/17/2021	Janus Henderson Group PLC	718,040	$49.08M	0.0%	N/A	1.103%
5/17/2021	Ameriprise Financial Inc.	51,171	$3.50M	0.0%	-11.4%	0.079%
5/17/2021	Hennion & Walsh Asset Management Inc.	97,498	$6.66M	0.4%	N/A	0.150%
5/17/2021	Nuveen Asset Management LLC	224,109	$15.32M	0.0%	-39.7%	0.344%
5/17/2021	Gilder Gagnon Howe & Co. LLC	263,420	$18.01M	0.1%	+160.0%	0.405%
5/17/2021	Novo Holdings A S	128,300	$8.77M	0.4%	+54.4%	0.197%
5/17/2021	Thrivent Financial for Lutherans	496,939	$33.97M	0.1%	+0.4%	0.764%
5/14/2021	Laurion Capital Management LP	9,872	$0.68M	0.0%	N/A	0.015%
5/14/2021	Brown Advisory Inc.	989,688	$67.64M	0.1%	+11.4%	1.521%
5/14/2021	Capital International Investors	5,578,232	$381.27M	0.1%	+4.6%	8.572%
5/14/2021	Capital Bank & Trust Co	67,154	$4.59M	0.1%	+3.1%	0.103%
5/14/2021	Yale University	11,668	$0.80M	1.7%	N/A	0.018%
5/14/2021	Weiss Multi Strategy Advisers LLC	88,711	$6.06M	0.1%	+706.8%	0.136%
5/14/2021	Dimensional Fund Advisors LP	16,625	$1.14M	0.0%	-38.3%	0.026%
5/14/2021	XTX Topco Ltd	3,106	$0.21M	0.1%	N/A	0.005%
5/14/2021	First Mercantile Trust Co.	1,603	$0.11M	0.0%	-10.5%	0.002%
5/14/2021	UBS Asset Management Americas Inc.	52,103	$3.56M	0.0%	+5.1%	0.080%
5/14/2021	Nicholas Investment Partners LP	375,654	$25.68M	1.8%	+38.9%	0.577%
5/14/2021	Monashee Investment Management LLC	100,000	$6.84M	1.1%	N/A	0.154%
5/14/2021	Stifel Financial Corp	2,564,822	$175.31M	0.3%	+0.9%	3.941%
5/14/2021	Credit Suisse AG	38,192	$2.61M	0.0%	-48.7%	0.059%
5/14/2021	O Shaughnessy Asset Management LLC	2,638	$0.18M	0.0%	-18.1%	0.004%
5/13/2021	Clearbridge Investments LLC	757,340	$51.76M	0.0%	+41.9%	1.164%
5/13/2021	Guggenheim Capital LLC	28,095	$1.92M	0.0%	+9.0%	0.043%
5/13/2021	Eversept Partners LP	242,172	$16.55M	1.3%	+133.4%	0.372%
5/13/2021	SG Americas Securities LLC	8,833	$0.60M	0.0%	-17.1%	0.014%
5/13/2021	Barclays PLC	40,248	$2.75M	0.0%	-71.3%	0.062%
5/13/2021	Pier Capital LLC	162,934	$11.14M	1.1%	+144.6%	0.250%
5/13/2021	Duality Advisers LP	33,196	$2.27M	0.2%	N/A	0.051%
5/13/2021	Mutual of America Capital Management LLC	78,063	$5.34M	0.1%	+79.6%	0.120%
5/13/2021	Amalgamated Bank	6,850	$0.47M	0.0%	-8.9%	0.011%
5/13/2021	ARS Investment Partners LLC	561,442	$38.38M	4.5%	+0.4%	0.905%
5/13/2021	ShoreHaven Wealth Partners LLC	2,439	$0.17M	0.1%	-17.9%	0.004%
5/13/2021	Bank of New York Mellon Corp	1,187,193	$81.15M	0.0%	+46.3%	1.914%
5/13/2021	Citigroup Inc.	67,163	$4.59M	0.0%	+352.5%	0.108%
5/13/2021	Mirae Asset Global Investments Co. Ltd.	14,364	$0.98M	0.0%	-5.3%	0.023%
5/13/2021	WCM Investment Management LLC	78,942	$5.40M	0.0%	-2.1%	0.127%
5/13/2021	Bank of Montreal Can	1,392	$98K	0.0%	-81.3%	0.002%
5/13/2021	Allianz Asset Management GmbH	30,939	$2.11M	0.0%	+29.1%	0.050%
5/12/2021	Northern Trust Corp	540,542	$36.95M	0.0%	-3.3%	0.871%
5/12/2021	Harbour Investments Inc.	1,816	$0.12M	0.1%	N/A	0.003%
5/12/2021	Geode Capital Management LLC	816,539	$55.81M	0.0%	+10.9%	1.316%
5/12/2021	Ensign Peak Advisors Inc	65,808	$4.50M	0.0%	+81.4%	0.106%
5/12/2021	Essex Investment Management Co. LLC	16,485	$1.13M	0.1%	N/A	0.027%
5/12/2021	JPMorgan Chase & Co.	1,754,456	$119.92M	0.0%	-13.1%	2.828%
5/12/2021	Panagora Asset Management Inc.	2,137	$0.15M	0.0%	-97.3%	0.003%
5/12/2021	Oak Ridge Investments LLC	37,790	$2.58M	0.2%	-1.3%	0.061%
5/12/2021	Sei Investments Co.	12,000	$0.82M	0.0%	+42.9%	0.019%
5/12/2021	E Fund Management Co. Ltd.	1,700	$0.12M	0.0%	N/A	0.003%
5/12/2021	Brinker Capital Investments LLC	3,914	$0.27M	0.0%	-14.6%	0.006%
5/12/2021	UBS Group AG	39,360	$2.69M	0.0%	+8.0%	0.063%
5/12/2021	Bellevue Group AG	36,000	$2.46M	0.0%	+188.0%	0.058%
5/11/2021	Aigen Investment Management LP	3,033	$0.21M	0.0%	N/A	0.005%
5/11/2021	Iridian Asset Management LLC CT	4,213	$0.29M	0.0%	N/A	0.007%
5/11/2021	Teacher Retirement System of Texas	5,597	$0.38M	0.0%	+22.8%	0.009%
5/11/2021	Elkhorn Partners Limited Partnership	1,000	$68K	0.0%	N/A	0.002%
5/11/2021	New York State Common Retirement Fund	54,607	$3.73M	0.0%	-2.3%	0.088%
5/11/2021	Fiera Capital Corp	45,153	$3.09M	0.0%	+3.6%	0.073%
5/11/2021	GW&K Investment Management LLC	105,712	$7.23M	0.1%	+4.5%	0.170%
5/11/2021	Nvwm LLC	12,726	$0.87M	0.3%	-1.3%	0.021%
5/11/2021	EAM Investors LLC	7,286	$0.50M	0.1%	-52.8%	0.012%
5/10/2021	Russell Investments Group Ltd.	28,789	$1.97M	0.0%	-37.3%	0.046%
5/10/2021	Tygh Capital Management Inc.	29,102	$1.99M	0.3%	+4.1%	0.047%
5/10/2021	L & S Advisors Inc	58,811	$4.02M	0.5%	-2.4%	0.095%
5/10/2021	Symmetry Investments LP	45,001	$3.08M	1.0%	+260.0%	0.073%
5/10/2021	Principal Financial Group Inc.	187,870	$12.84M	0.0%	+540.2%	0.303%
5/10/2021	Rafferty Asset Management LLC	40,868	$2.79M	0.0%	+282.7%	0.066%
5/10/2021	Shell Asset Management Co.	2,631	$0.18M	0.0%	-43.1%	0.004%
5/7/2021	Advisors Asset Management Inc.	21,803	$1.49M	0.0%	+6.7%	0.035%
5/7/2021	BlackRock Inc.	3,783,554	$258.61M	0.0%	+7.3%	6.098%
5/7/2021	American International Group Inc.	30,753	$2.10M	0.0%	-0.9%	0.050%

Data available starting January 2016

Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological diseases and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as id developing Rimegepant for preventive treatment of migraine and other non-migraine indications; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as respiratory complications and non-migraine studies; and BHV-3100 for non-migraine indications. The company also offers Troriluzole, which is in phase III clinical trials for spinocerebellar ataxia and obsessive compulsive disorders, as well as Alzheimer diseases; BHV-0223, a product for amyotrophic lateral sclerosis; BHV-5000/5500 that is in phase I clinical trial for neuropsychiatric indications; and Verdiperstat, a product that is in phase III trial for multiple system atrophy and amyotrophic lateral sclerosis. Biohaven Pharmaceutical Holding Company Ltd. has a collaboration agreement with Cove to facilitate telemedicine evaluation for migraine sufferers. The company was incorporated in 2013 and is headquartered in New Haven, Connecticut.

Today's Range

Now: $100.40

$100.17

$106.50

50 Day Range

MA: $78.22

$65.78

$105.02

52 Week Range

Now: $100.40

$57.66

$106.57

Volume

1,063,718 shs

Average Volume

618,274 shs

Market Capitalization

$6.53 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.01

Who are the company insiders with the largest holdings of Biohaven Pharmaceutical?

Biohaven Pharmaceutical's top insider shareholders include:

Gregory Bailey (Director)
John W Childs (Director)
Declan Doogan (Director)
Robert Berman (Insider)
John Tilton (Insider)
William A Jones Jr (Insider)
Eric Aguiar (Director)
Kimberly Gentile (SVP)
Elyse Stock (Insider)
James Engelhart (CFO)
John W Childs (Director)
Vlad Coric (CEO)

Who are the major institutional investors of Biohaven Pharmaceutical?

Biohaven Pharmaceutical's top institutional shareholders include:

Capital International Investors — 8.57%
BlackRock Inc. — 6.10%
Stifel Financial Corp — 3.94%
JPMorgan Chase & Co. — 2.83%
Alliancebernstein L.P. — 2.35%
Bank of New York Mellon Corp — 1.91%

Which major investors are selling Biohaven Pharmaceutical stock?

During the last quarter, BHVN stock was sold by these institutional investors:

JPMorgan Chase & Co.
Cormorant Asset Management LP
Nuveen Asset Management LLC
Morgan Stanley
Barclays PLC
Opaleye Management Inc.
Panagora Asset Management Inc.
D. E. Shaw & Co. Inc.

In the last year, company insiders that have sold Biohaven Pharmaceutical company stock include:

Gregory Bailey (Director)
John W Childs (Director)
Declan Doogan (Director)
Robert Berman (Insider)
John Tilton (Insider)

Which major investors are buying Biohaven Pharmaceutical stock?

Within the previous quarter, BHVN stock was acquired by institutional investors including:

Janus Henderson Group PLC
Glenview Capital Management LLC
Armistice Capital LLC
Bank of New York Mellon Corp
Oak Ridge Investments LLC
BlackRock Inc.
Alliancebernstein L.P.
Capital International Investors

During the last year, these company insiders have bought Biohaven Pharmaceutical stock:

Gregory Bailey (Director)
John W Childs (Director)
Declan Doogan (Director)
Robert Berman (Insider)
John Tilton (Insider)

Here’s the Safest Way to Get Insanely Rich in the 2021 Gold Bull Market

From Resource Stock Digest | Ad

Get the details here...